• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Donna L. Berry, PhD, RN, AOCN, FAAN

Associate Professor, Department of Medicine, Harvard Medical School

Director, Phyllis F. Cantor Center for Research in Nursing & Patient Care Services, Dana-Farber Cancer Institute

Contact Info

Donna Berry
Dana-Farber Cancer Institute
450 Brookline Avenue

Boston, MA, 02215
Phone: 617-632-1909
donna_berry@dfci.harvard.edu

Assistant

Taylor Hendel
Administrative Specialist
Dana-Farber Cancer Institute
Phone: 617-632-1925
taylor_hendel@dfci.harvard.edu

DF/HCC Program Affiliation

Prostate Cancer

Lab Website

Cantor Center

Research Abstract

OBJECTIVE: The purpose of this trial was to compare usual patient education plus the Internet-based, Personal Patient Profile-Prostate, versus usual education alone, on conflict associated with decision making, plus explore time-to-treatment and treatment choice.
METHODS: A randomized, multi-center clinical trial was conducted with measures at baseline, one and six months. Men with newly diagnosed localized prostate cancer who sought consultation at urology, radiation oncology or multi-disciplinary clinics in four geographically-distinct American cities were recruited. Intervention group participants used the Personal Patient Profile-Prostate, a decision support system comprised of customized text and video coaching regarding potential outcomes, influential factors, and communication with care providers. The primary outcome, patient-reported decisional conflict, was evaluated over time using Generalized Estimating Equations to fit generalized linear models. Additional outcomes, time-to-treatment, treatment choice and program acceptability/usefulness, were explored.
RESULTS: A total of 494 eligible men were randomized (266 intervention; 228 control). The intervention reduced adjusted decisional conflict over time as compared with the control group, for the uncertainty score (estimate -3.61; (confidence interval, -7.01,-0.22) and values clarity (estimate-3.57; confidence interval (-5.85,-1.30) Borderline effect was seen for the total decisional conflict score (estimate -1.75; confidence interval (-3.61,0.11). Time-to-treatment was comparable between groups, while undecided men in the intervention group chose brachytherapy more often than in the control group. Acceptability and usefulness were highly rated.
CONCLUSION: The Personal Patient Profile-Prostate is the first intervention to significantly reduce decisional conflict in a multi-center trial of American men with newly diagnosed localized prostate cancer. Our findings support efficacy of P3P for addressing decision uncertainty and facilitating patient selection of a prostate cancer treatment that is consistent with the patient values and preferences.

Publications

View All Publications